Recent studies suggest that ATF3 (Activating Transcription Factor 3), a transcription factor responding to diverse cellular stresses and regulating oncogenic activities, acts as a tumor suppressor for the subset of prostate cancers harboring dysfunctional PTEN [252]. This evidence concerns the gene ATF3 and neoplasm.